Africa & Middle East

More than 600 delegates are expected to attend the Region’s main annual forum for health governance and policymaking.

The partnership will support Nigeria’s post-marketing vaccine surveillance system by evaluating innovative screening devices and expanding routine laboratory testing for vaccine lots.

Its educational programs cover pediatric dentistry, airway health, sleep-disordered breathing, oral function, early facial growth, interceptive orthodontics and myofunctional therapy.

The government gazetted the new status on July 24, 2026, marking a significant step in the development of specialised infectious disease services, research and training in the country.

The partnership will unlock KSh10.4 billion (US$80 million) over the next five years to accelerate implementation of Kenya’s Every Woman Every Newborn Everywhere (EWENE) Acceleration Plan and support the country’s 90-90-80-80 maternal and newborn health targets.

The expanded role is expected to strengthen referral services across Western Kenya and the wider East African region while reducing pressure on national referral hospitals.

The survey will involve about 10,000 pregnant women across all 10 regions of Cameroon.

The findings will inform a continental report intended to support evidence-based policymaking, strengthen accountability and accelerate efforts to prevent maternal and newborn deaths across Africa.

Under the agreements, MSD will work with Aspen Pharmacare in South Africa, Quality Chemicals Industries Limited (QCIL) in Uganda and Universal Corporation Limited (UCL) in Kenya.

Throughout the 42-day period, health authorities maintained enhanced nationwide surveillance and found no evidence of further transmission.